Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Guanine nucleotides in DNA refer to the **deoxyribonucleotide units containing the base guanine**, a purine nitrogenous base (C\(_5\)H\(_5\)N\(_5\)O), which pair specifically with cytosine via three hydrogen bonds, stabilizing the DNA double helix[1][2][3][4][5][7]. The arrangement and sequence of guanine bases within DNA encode genetic information and play a crucial role in defining the genetic code and gene expression[3][7]. Alterations or lesions involving guanine can contribute to mutations and disease, but "guanine nucleotides in DNA" as a phrase does not define a discrete, actionable molecular target[2][3][6]. Key points: - **Guanine** is a fundamental DNA building block but not a "target" in the biological sense of drug or therapeutic intervention[1][3][4][6]. - If a specific guanine-modifying enzyme, nucleotide transporter, or guanine-related protein is intended, a more precise name is required. **This entry is not a recognized molecular target or receptor.**
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Guanine nucleotide in DNA (G (only in the context of nucleic acid notation, not as a target abbreviation)).